Skip to main content
Fig. 1 | BMC Medical Genomics

Fig. 1

From: Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation

Fig. 1

The impact of SPAG1 expression on survival of AML patients. a The effect of SPAG1 expression on overall survival in whole-cohort AML, non-M3 AML, and CN-AML from TCGA dataset. b The effect of SPAG1 expression on disease/leukemia free survival in in whole-cohort AML, non-M3 AML, and CN-AML from TCGA dataset. c SPAG1 expression in AML from TCGA dataset. d The effect of SPAG1 expression on overall survival in 78 and 162 CN-AML from the GEO dataset (GSE12417) analyzed by the online web tool Genomicscape (http://genomicscape.com/microarray/survival.php). e The effect of SPAG1 expression on event-free survival and overall survival in AML from GEO datasets (GSE6891 and GSE37642)

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us